ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Pharma services firm Ardena changes private equity hands

by Rick Mullin
January 24, 2020 | APPEARED IN VOLUME 98, ISSUE 4

 

09804-buscon14-ardena.jpg
Credit: Ardena
The former ChemConnection facility in the Netherlands

The private equity firm GHO Capital Partners has acquired Ardena, a pharmaceutical services firm focused on early-stage drug development, from Mentha Capital. Belgium-based Ardena has grown through recent acquisitions, including Syntagon in Sweden and ChemConnection in the Netherlands. Last year, GHO invested in Sterling Pharma Solutions, a British drug services firm, and BioAgilytix, a pharmacokinetics analysis specialist in Durham, North Carolina.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment